Why is the cost of cutting-edge therapies a barrier?
Innovative treatments such as immunotherapy and targeted therapy have revolutionized cancer care but come with high costs. These expenses can be prohibitive for many patients, even in developed countries. Insurance coverage is often limited, and out-of-pocket costs can be financially devastating, leading to suboptimal treatment adherence.